Target intelligence / Profile preview

Bacterial peptidoglycan beta-(1,4)-glycosidic bond

Molecular classification
Polysaccharide, Bacterial cell wall component
01

Overview

The bacterial peptidoglycan beta-(1,4)-glycosidic bond is the fundamental structural linkage that connects N-acetylmuramic acid (NAM) and N-acetylglucosamine (NAG) to form the glycan backbone of the bacterial cell wall (Salton & Kim, 1996, Medical Microbiology). This polymer provides the mechanical strength and rigidity required for bacteria to maintain their shape and survive high internal osmotic pressures (Schleifer & Kandler, 1972, Bacteriological Reviews). This specific bond is the primary target of the innate immune enzyme lysozyme (muramidase), which catalyzes its hydrolysis, leading to the loss of cell wall integrity and subsequent osmotic lysis of the bacterium (Raghavan & Groisman, 2015, Annual Review of Microbiology). While most clinical antibiotics like beta-lactams inhibit the synthesis or cross-linking of peptidoglycan, the NAM-NAG glycosidic bond represents a target for degradative enzymes and antimicrobial peptides (Callewaert & Michiels, 2010, Journal of Biosciences). Therapeutic interest in this target often focuses on the use of exogenous lysozymes or engineered endolysins to treat multi-drug resistant infections, particularly those caused by Gram-positive pathogens. However, the rapid breakdown of this bond can release pro-inflammatory peptidoglycan fragments, such as muramyl dipeptide, which may trigger systemic inflammatory responses through NOD-like receptors (Callewaert & Michiels, 2010, Journal of Biosciences).

Other names
NAM-NAG bondPeptidoglycan glycosidic linkagebeta-1,4-glycosidic bondMuramidase target bondBacterial peptidoglycan bonds between N-acetylmuramic acid and N-acetylglucosamine
02

Mechanism of action

Enzymatic hydrolysis of the beta-(1,4)-glycosidic linkage between N-acetylmuramic acid and N-acetylglucosamine residues in the peptidoglycan backbone.

03

Biological functions

Cell wall structural integrityOsmotic protectionBacterial morphogenesis
04

Disease associations

Bacterial infection
05

Safety considerations

Pro-inflammatory response to peptidoglycan fragmentsJarisch-Herxheimer reactionCytokine release syndrome
06

Interacting drugs

Lysozyme

2 more in the full profile.

07

Biomarkers

Muramyl dipeptide (MDP)Soluble peptidoglycan fragments

Beyond the preview

Go deeper on Bacterial peptidoglycan beta-(1,4)-glycosidic bond.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial peptidoglycan beta-(1,4)-glycosidic bond.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call